环林-G关联激酶 (GAK) 是一种新型的线粒激酶,也是扩散大B细胞淋巴瘤的治疗点
bioRxiv : the preprint server for biology
|November 1, 2024
概括
向环林G相关激酶 (GAK) 通过破坏线粒分裂,有效地杀死扩散大B细胞淋巴瘤 (DLBCL) 细胞. 这种新的治疗策略对治疗DLBCL充满希望,特别是在RB1功能丧失的患者中.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种具有显著异质性的攻击性血液性恶性瘤.
- 很大一部分DLBCL患者无法通过标准化疗免疫疗法治愈,因此需要新的治疗方法.
- 确定新的,可用药的点对于改善DLBCL治疗结果至关重要.
研究的目的:
- 为了确定DLBCL治疗的新,瘤选择性标.
- 调查环林G相关激酶 (GAK) 作为DLBCL潜在治疗点的作用.
- 探索GAK抑制的机制及其对DLBCL细胞周期进展的影响.
主要方法:
- 对DLBCL细胞系和非恶性对照对酶抑制剂的表型查.
- 细胞周期分析和免疫光共聚焦显微镜以评估GAK抑制效应.
- 临床DLBCL样本的RNA测序分析,以将GAK表达与RB1缺乏相关联.
- 在NSG小鼠中使用DLBCL异种移植模型的体内研究.
主要成果:
- 鉴定出环林G相关激酶 (GAK) 是一种瘤选择性标,其抑制有选择性地杀死DLBCL细胞.
- 在DLBCL细胞中,GAK抑制诱导了G2/M阶段细胞周期停止,染色体不对齐和扭曲.
- 增加的GAK表达与DLBCL中的RB1缺乏有很强的相关性,这表明在RB缺乏细胞中对GAK对线粒性进展的依赖.
- 有针对性的GAK抑制导致DLBCL异种移植小鼠模型中的瘤负担显著降低.
结论:
- GAK是DLBCL治疗的新,可用药的标.
- 抑制GAK会破坏线粒分裂并选择性地消除DLBCL细胞,特别是那些RB1功能丧失的细胞.
- 针对GAK为DLBCL患者的一个子集提供了一个有前途的治疗策略,解决了一个关键的未满足需求.
更多相关视频
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
11.8K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
相关概念视频
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Positive Regulator Molecules
5.4K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
